Structure |
Chemical Name |
CAS |
MF |
![(S)-1-メトキシ-2-メチルオキシ-3-ヒドロキシ-7-アセチルアミノ-10-メチルチオ-6,7-ジヒドロベンゾ[a]ヘプタレン-9(5H)-オン](/CAS/GIF/87424-25-7.gif) |
(S)-1-メトキシ-2-メチルオキシ-3-ヒドロキシ-7-アセチルアミノ-10-メチルチオ-6,7-ジヒドロベンゾ[a]ヘプタレン-9(5H)-オン |
87424-25-7 |
C21H23NO5S |
 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2607-52-5 |
C15H22O |
 |
(4S)-2-アセチル-3,5β,6α,10,12,12aβ-ヘキサヒドロキシ-4β-(ジメチルアミノ)-6-メチル-1,4,4aβ,5,5aβ,6,11,12a-オクタヒドロナフタセン-1,11-ジオン |
6542-44-5 |
C23H25NO8 |
 |
6,8,11-トリヒドロキシ-1-メトキシ-5,12-ナフタセンジオン(DOXORUBICIN IMPURITY) |
64845-67-6 |
C19H12O6 |
 |
(S)-4-(4-Nitrobenzyl)-2-oxazolidinone |
139264-55-4 |
C10H10N2O4 |
 |
2-(4-Hydroxymethylphenyl)phenylsulfonamide |
158144-55-9 |
C15H14O3 |
![4-[2-(シクロプロピルメトキシ)エチル]フェノール](/CAS/GIF/63659-16-5.gif) |
4-[2-(シクロプロピルメトキシ)エチル]フェノール |
63659-16-5 |
C12H16O2 |
 |
2-(2-クロロエチル)チオフェン |
19995-38-1 |
C6H7ClS |
 |
N-Methyl Pantoprazole, mixture of 1 and 3 isomers |
624742-53-6 |
C17H17F2N3O4S |
 |
rel-(αR*,α'S*)-1-メチル-α,α'-ジフェニル-2α*,6α*-ピペリジンジエタノール |
552-72-7 |
C22H29NO2 |
 |
4-Amino-1-3,5-di-O-benzoyl-2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone |
134790-40-2 |
C23H19F2N3O6 |
 |
9'-DESMETHYL GRANISETRON (グラニセトロン不純物C) |
160177-67-3 |
C17H22N4O |
![3-[4-[エチル]フェノキシ]-1-(イソプロピルアミノ)-2-プロパノール](/CAS/20200119/GIF/67193-95-7.gif) |
3-[4-[エチル]フェノキシ]-1-(イソプロピルアミノ)-2-プロパノール |
67193-95-7 |
C14H23NO2 |
 |
3,5-ビス(ベンジルオキシ)安息香酸ベンジル |
50513-72-9 |
C28H24O4 |
![[(2,3-ジヒドロ-1,5-ジメチル-3-オキソ-2-フェニル-1H-ピラゾール-4-イル)アミノ]メタンスルホン酸](/CAS/GIF/117-38-4.gif) |
[(2,3-ジヒドロ-1,5-ジメチル-3-オキソ-2-フェニル-1H-ピラゾール-4-イル)アミノ]メタンスルホン酸 |
117-38-4 |
C12H15N3O4S |
 |
4-メチルけい皮酸エチル |
24393-49-5 |
C12H14O2 |
 |
3-(2-ヒドロキシエチル)アミノプロピオニトリル |
33759-44-3 |
C5H10N2O |
 |
2-アミノ-5-ブロモベンズアルデヒド |
29124-57-0 |
C7H6BrNO |
 |
(R)-1-(2-チエニル)-3-(メチルアミノ)-1-プロパノール |
116539-57-2 |
C8H13NOS |
 |
3-OXO-3,4-DIHYDROPYRAZINE-2-CARBONITRILE |
81411-78-1 |
C5H3N3O |
 |
RP 48497 (Eszopiclone Impurity C) |
148891-53-6 |
C11H7ClN4O |
 |
3-(1-methyl-1H-indole-3-carbonyl)hexanedioic acid |
1352491-75-8 |
C16H17NO5 |
 |
デクラジノースロキシスロマイシン (ROXITHROMロキシトロマイシン不純物B |
214902-82-6 |
C33H62N2O12 |
 |
Unii-o0p4I5851i |
139563-29-4 |
C28H37ClN4O2S |
 |
デヒドロモナコリンK |
109273-98-5 |
C24H34O4 |
 |
(2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane |
13529-31-2 |
C33H54N2O4 |
 |
Palbociclib Impurity 59 |
1430196-98-7 |
C14H20N4O4 |
 |
Landiolol impurity Z |
|
|
 |
Vitamin K1 Impurity 1 |
19274-66-9 |
C31H46O2 |
 |
Teneligliptin Impurity 13 |
|
|
 |
Ceftazidime EP Impurity D |
73547-69-0 |
C45H44N6O7S2 |
 |
Nicergoline EP Impurity G |
57935-65-6 |
C23H24BrN3O2 |
![Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20200401/GIF/2356153-95-0.gif) |
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
 |
2-Pyrrolidinecarbonitrile, 1-(2-aminoacetyl)-, hydrochloride (1:1), (2S)- |
913980-23-1 |
C7H12ClN3O |
 |
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
 |
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine](/CAS/20200401/GIF/127017-42-9.gif) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine |
127017-42-9 |
C21H25NO4 |
 |
Methylprednisolone Impurity 21 |
150899-33-5 |
C22H28O4 |
 |
Epinephrine Impurity 7 |
62322-82-1 |
C9H11NO3 |
 |
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
Fesoterodine Impurity 14 |
|
|
 |
Dexamethasone EP impurities E |
|
|
 |
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
 |
Empagliflozin Impurity 57(R,R) |
|
|
 |
Aripiprazole peroxide degradation Impurity (MW:303Da) |
|
|
 |
Pramipexole Impurity Reference |
|
|
 |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+ |
|
|
![3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester](/CAS/20200515/GIF/100688-45-7.gif) |
3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester |
100688-45-7 |
C13H14O4 |
 |
Acetaminophen Impurity 14 |
1991204-56-8 |
C16H18N2O2 |
 |
Ketoconazole Impurity 7 |
172032-21-2 |
C11H12Cl2O3 |
 |
Rosuvastatin Impurity 59 |
|
|
 |
Losartan Impurity 12 |
727718-93-6 |
C22H22ClN9 |
 |
benzyl (2S)-2-amino-3-(4-methanesulfonylphenyl)propanoate hydrochloride |
1865726-28-8 |
C17H19NO4S |
 |
Glycopyrrolate Impurity 12 |
857353-41-4 |
C13H14O3 |
 |
(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
4660-26-8 |
C22H22N2O8 |
 |
Regorafenib Impurity 38 |
|
|
 |
Cefazolin Impurity 28 |
|
|
 |
Vonoprazan Impurity 57 |
|
|
 |
Tafluprost Impurity 9 |
2099033-66-4 |
C27H41NO8 |
![2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy-](/CAS/20200515/GIF/2253977-80-7.gif) |
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253977-80-7 |
C27H36N2O6 |
![Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester](/CAS/20211123/GIF/1187954-56-8.gif) |
Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester |
1187954-56-8 |
C33H41NO4 |
![N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate)](/CAS/20210111/GIF/1054332-15-8.gif) |
N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate) |
1054332-15-8 |
C19H25F3N7O6PS2 |
![N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide](/CAS/20200611/GIF/2211059-00-4.gif) |
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
2211059-00-4 |
C19H21BrN6O4S |
 |
Isomer 1 of Tazobactam Impurity 3 |
|
|
 |
Ceftiofur USP Impurity I |
|
|
 |
Cephalexin Degradation Impurity A |
|
|
 |
Pregabalin-8687(mixture of 4 isomers) |
|
|
![7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one](/) |
7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one |
|
|
![1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one](/) |
1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one |
|
|
 |
(E)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
 |
Dolutegravir Impurity C |
1802141-49-6 |
C22H23F2N3O5 |
 |
Dapoxetine Impurity 68 |
119357-48-1 |
C19H18O |
 |
Tobramycin Impurity |
74501-86-3 |
C18H35N5O8 |
 |
Peramivir Impurity 24 |
|
|
 |
2-CHLORO-6-AMINO-9-(2',3',5'-TRI-O-ACETYL--D-RIBOFURANOSYL)PURINE |
79999-39-6 |
C16H18ClN5O7 |
 |
Sugammadex sodium Impurity 46 |
|
|
 |
Tenofovir Impurity 103 |
|
|
 |
Cabozantinib impurity 44 |
|
|
 |
Cabozantinib impurity 40 |
|
|
 |
Cabozantinib impurity 74 |
|
|
 |
Doxofylline Impurity 25 |
|
|
![2-メトキシ-4-[(E)-1-プロペニル]フェノール](/CAS/GIF/5932-68-3.gif) |
2-メトキシ-4-[(E)-1-プロペニル]フェノール |
5932-68-3 |
C10H12O2 |
![3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン](/CAS/GIF/25517-72-0.gif) |
3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン |
25517-72-0 |
C5H10N2O2S |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
 |
Sitagliptin EP Impurity 7 |
|
|
 |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
 |
Beprostatin impurity 4 |
|
|
 |
N-(メトキシカルボニル)-p-トルエンスルホンアミド |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
 |
(S)-レパグリニドエチルエステル (REPAGLINIDE IMPURITY) |
147770-06-7 |
C29H40N2O4 |
 |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
 |
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
 |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
 |
Isavuconazole Impurity 37 |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
 |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
 |
Mannitol EP impurity B |
|
|
 |
Mannitol EP impurity A |
|
|